Elizabeth Brint

Elizabeth Brint

Auto-generated profile, based on publicly available information

Elizabeth Brint

School of Medicine, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Nature Reviews Immunology
Verified
Journal Article
Closed access
FLFoo Y. Liew
Foo Y. Liew
DXDamo Xu
Damo Xu
EBElizabeth K. Brint
Elizabeth K. Brint
Luke O'NeillLuke O'Neill
Luke O'Neill

6 September 2001 in Nature
Verified
Journal Article
Closed access
PDF file
KFKate Fitzgerald
Kate Fitzgerald
EPEva M. Palsson-McDermott
Eva M. Palsson-McDermott
ABAndrew Bowie
Andrew Bowie
CJCaroline A. Jefferies
Caroline A. Jefferies
AMAshley S. Mansell
Ashley S. Mansell
Luke O'NeillLuke O'Neill
Luke O'Neill

7 March 2004 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
EBElizabeth K Brint
Elizabeth K Brint
DXDamo Xu
Damo Xu
HLHaiying Liu
Haiying Liu
ADAisling Dunne
Aisling Dunne
AMAndrew N J McKenzie
Andrew N J McKenzie
FLFoo Y Liew
Foo Y Liew

1 July 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CJCaroline A. Jefferies
Caroline A. Jefferies
SDSarah Doyle
Sarah Doyle
CBCornelia Brunner
Cornelia Brunner
ADAisling Dunne
Aisling Dunne
EBElizabeth Brint
Elizabeth Brint
Luke O'NeillLuke O'Neill
Luke O'Neill
In this study we have identified members of the Toll-like receptor (TLR) family (namely, TLRs 4, 6, 8, and 9) as proteins to which the intracellular protein tyrosine kinase, Bruton's tyrosine kinase (Btk), binds. Detailed analysis of the interaction between Btk and TLR8 demonstrates that the presence of both Box 2 and 3 motifs in the Toll/interleukin-1 receptor domain was required for the interaction. Furthermore, co-immunoprecipitation experiments revealed that Btk can also interact with key proteins involved in TLR4 signal transduction, namely, MyD88, Mal (MyD88 adapter-like protein), and interleukin-1 receptor-associated kinase-1, but not TRAF-6. The ability of Btk to interact with TLR4 and Mal suggests a role for Btk in lipopolysaccharide (LPS) signal transduction. Stimulation of the human monocytic cell line THP-1 with LPS resulted in an increase in the level of tyrosine phosphorylation of Btk (indicative of activation). The autokinase activity of Btk was also stimulated after LPS stimulation. In addition, a dominant negative form of Btk inhibited TLR4-mediated activation of a nuclear factor κB (NFκB)-dependent reporter gene in HEK293 cells as well as LPS-induced activation of NFκB in the astrocytoma cell line U373 and the monocytic cell line RAW264.7. Further investigation revealed that the Btk-specific inhibitor, LFM-A13, inhibited the activation of NFκB by LPS in THP-1 cells. Our findings implicate Btk as a Toll/interleukin-1 receptor domain-binding protein that is important for NFκB activation by TLR4.

7 June 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
KBKevin J. Baker
Kevin J. Baker
AHAileen Houston
Aileen Houston
EBElizabeth Brint
Elizabeth Brint
The IL-1 family of cytokines currently comprises of seven ligands with pro-inflammatory activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL-36γ) as well as two ligands with anti-inflammatory activity (IL-37, IL-38). These cytokines are known to play a key role in modulating both the innate and adaptive immunes response, with dysregulation linked to a variety of autoimmune and inflammatory diseases. Given the increasing appreciation of the link between inflammation and cancer, the role of several members of this family in the pathogenesis of cancer has been extensively investigated. In this review, we highlight both the pro- and anti-tumorigenic effects identified for almost all members of this family, and explore potential underlying mechanisms accounting for these divergent effects. Such dual functions need to be carefully assessed when developing therapeutic intervention strategies targeting these cytokines in cancer.

1 February 2011 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
EBElizabeth K Brint
Elizabeth K Brint
JMJohn Mac MacSharry
John Mac MacSharry
AFAine Fanning
Aine Fanning
FSFergus Shanahan
Fergus Shanahan
EQEamonn M M Quigley
Eamonn M M Quigley
The pathogenesis of irritable bowel syndrome (IBS) is poorly understood. One contributory factor may be low-grade mucosal inflammation, perhaps initiated by the microbiota. Toll-like receptors (TLRs) are a family of pathogen-recognition receptors of the innate immune system. The aim of this study was to evaluate the potential involvement of TLRs in IBS to further understand the involvement of the innate immune system in this complex disorder. The expression of TLRs was investigated in colonic biopsy samples obtained from 26 IBS patients and compared with 19 healthy controls. Protein expression of TLR4, TLR7, and TLR8 was confirmed by immunofluorescence and alterations in the TLR4 protein were confirmed by western blot. Quantitative reverse transcriptase-PCR showed increased levels of TLR4 (P≤0.001) and TLR5 (P=0.0013) and decreased levels of TLR7 (P≤0.001) and TLR8 (P=0.0019) in IBS patients. Our results support the presence of an immune engagement between the microbiota and the host in IBS; an interaction that involves innate immunity and could generate a low-grade inflammatory response. These findings could also offer an additional biomarker of the disease or a disease subset.